ethyl 3-[(1-methoxypropan-2-yl)amino]pyridine-2-carboxylate
95%
- Product Code: 181017
CAS:
1660120-60-4
Molecular Weight: | 238.28 g./mol | Molecular Formula: | C₁₂H₁₈N₂O₃ |
---|---|---|---|
EC Number: | MDL Number: | ||
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | 2-8°C |
Product Description:
Used as an intermediate in the synthesis of pharmaceuticals, particularly in the development of nicotinic acetylcholine receptor modulators. It serves as a building block for compounds targeting neurological disorders such as depression, anxiety, and cognitive impairment. Its structure allows for selective interaction with receptor subtypes, making it valuable in medicinal chemistry for optimizing drug potency and reducing side effects. Also employed in research settings to develop novel analogs with improved metabolic stability and bioavailability.
Sizes / Availability / Pricing:
Size | Availability | Price | Quantity |
---|---|---|---|
250mg | 10-20 days | Ft255,795.05 |
+
-
|
ethyl 3-[(1-methoxypropan-2-yl)amino]pyridine-2-carboxylate
Used as an intermediate in the synthesis of pharmaceuticals, particularly in the development of nicotinic acetylcholine receptor modulators. It serves as a building block for compounds targeting neurological disorders such as depression, anxiety, and cognitive impairment. Its structure allows for selective interaction with receptor subtypes, making it valuable in medicinal chemistry for optimizing drug potency and reducing side effects. Also employed in research settings to develop novel analogs with improved metabolic stability and bioavailability.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
Ft0.00
Ft0.00
Total :